TerSera Therapeutics is a biopharmaceutical company with a focus on oncology and rare disease, and its growth is powered by acquisitions. That makes finance the engine room of the company. Every potential deal needs responsive scenario modeling, trustworthy numbers, and answers that leadership can quickly act on before the opportunity moves on.
“We’re very acquisitive, so we are constantly looking for deal opportunities,” says Avra Mouzakis, Associate Director of Enterprise Financial Performance Management. “It’s very important to be able to look at different scenarios and be agile in that way.”
With Planful in place, TerSera Therapeutics has:
TerSera’s growth strategy is fueled by acquisitions, which means finance can’t afford to move slowly. Fast scenario modeling, reliable numbers, and the ability to answer complex questions keep the business moving forward.
Running scenarios and trusting the results wasn’t possible with layered spreadsheets. Too much time went into keeping models intact and data trustworthy. Analysis took a back seat to validation, and leadership conversations centered on whether the numbers were right, not what they meant for the business.
That is a real constraint when every deal depends on quickly understanding how the business performs under different conditions.
“It was slow. There wasn’t much ability to adjust on the fly,” says Avra. “It quickly became clear that in order to scale, we needed a financial planning tool.”
TerSera needed a platform that could centralize planning, automate reporting, and support the kind of fast, flexible scenario modeling an acquisitive company depends on.
Several capabilities played an important role in that decision:
What followed was a transformation that reached well beyond the finance team.
The TerSera team uses Planful AI for Finance across the planning cycle, with each layer contributing at a different moment:
Trust was the prerequisite
Before the team brought Planful AI on board, they pressure-tested it with TerSera’s Chief Data Officer. The bar was high.
“Planful AI has created their tool in a very ethically responsible and careful way,” Avra says. “I think that can’t be said for all large language models out there. It’s something that I really value and was very critical to us when we were even considering bringing Planful AI on board at TerSera.”
By adopting Planful, TerSera’s finance team gained the speed and capacity to plan at the pace of the business.
While time saved has made a measurable impact in TerSera’s day-to-day operations, the most meaningful shift has been in how finance shows up for the business.
“The conversations that we have with leadership have changed from what is the number to what does that number mean for our future,” Avra says.
With access to trusted, real-time data, the team can weigh in earlier on acquisition decisions, bringing clarity to leadership before opportunities move forward. Budget owners are more engaged because they built the plan themselves, and 80 to 85% of the people working in Planful sit outside finance. Accountability is embedded at every step of the process. Finance has moved from maintaining the numbers to helping the business decide what to do with them.
For a company that depends on speed and agility to stay ahead of acquisition opportunities, Planful makes that shift possible.
“It’s hard to imagine our lives without Planful,” Avra says, “and I really don’t want to.”
TerSera Therapeutics is a biopharmaceutical company with a focus on oncology and rare disease.
Pharmaceutical Manufacturing
170
Deerfield, IL
Planful AI, Spotlight, Dynamic Planning, Structured Planning
